Preservative-free artificial tears after LASIK
Get single-use, preservative-free vials, not a shared multi-use bottle — dry eye is the single most common thing that happens after LASIK, and a 2023 FDA Class I recall traced a serious contamination outbreak directly to a reused multi-use eye-drop bottle. The two picks below are the same brand family, single-use format; the only real choice is box size.
Checked two preservative-free tears options against FDA's own LASIK guidance and a live FDA recall pull — how we choose →
2 picks we checked
Refresh Preservative-free artificial tears (single-use vials)
$22.26 checked 2026-07-30
The larger 60-count box — buy this unless you want to try a smaller box first.
FDA's own LASIK patient page says you'll likely be advised to use artificial tears after your first post-op visit, and both hospital sources in this research pass name dry eye as the most common side effect. Single-use, preservative-free vials avoid the preservative buildup that can irritate a healing eye with repeated daily use over the first weeks.
Flaw: Single-use vials cost more per drop than a multi-use bottle — the trade-off for the format the 2023 recall makes a real argument for.
See the REFRESH OPTIVE Preservative-Free Tears on Amazon →
Refresh Preservative-free artificial tears (single-use vials, budget)
$16.08 checked 2026-07-30
Same brand family, same single-use format, fewer vials at a lower box price.
Same brand family, same single-use preservative-free vial format, fewer vials per box at a lower per-box price -- a reasonable budget alternate for anyone who wants to try a smaller box before committing to a larger one.
Flaw: 50 vials instead of 60 — you'll likely need to reorder sooner if you're using drops several times a day.
See the REFRESH PLUS Preservative-Free Tears on Amazon →Why single-use, not a multi-use bottle
This is the real decision in this category — not which brand, but which format.
In 2023, FDA issued a Class I recall — its most serious classification — of EzriCare and Delsam Pharma artificial tears (400,008 bottles) after finding bacterial contamination in unopened product. The CDC linked the outbreak to 55 infections across 12 states, one death, and permanent vision loss in some patients.
FDA named the root cause directly: the manufacturer distributed ophthalmic drops in multi-use bottles without an adequate preservative, plus a lack of proper microbial testing and tamper-evident packaging. A single-use, preservative-free vial removes the specific pathway this outbreak traced to — it can't be reopened, reused, and recontaminated the way a shared bottle can.
This wasn't an isolated incident. The same live openFDA query that surfaced the EzriCare recall also found three more Class I lubricant-eye-drop recalls in the following two years — including major, mainstream retail brands, not just a fringe generic:
- CVS Health Lubricant Eye Drops (386,256 bottles) — Kilitch Healthcare India Limited, Nov. 2023, non-sterility.
- CVS Health Mild Moderate Lubricating Eye Drops (45,408 bottles) — same manufacturer, same recall wave.
- Systane Lubricant Eye Drops, Ultra PF (preservative-free) (55,960 25-count boxes) — Alcon Research LLC, Dec. 2024, non-sterility.
The honest limit of this reasoning: the Alcon Systane recall was preservative-free, single-use vials — the exact format both picks above use. Single-use vials remove the reused-bottle contamination pathway the EzriCare outbreak traced to; they don't make manufacturing contamination impossible in general. No recall has been issued for either REFRESH product recommended on this page as of this check.
FSA/HSA eligibility — what we can and can't confirm
IRS Publication 502 confirms LASIK surgery itself is FSA/HSA eligible, and over-the-counter lubricating eye drops are commonly eligible for FSA/HSA reimbursement under Publication 969's general OTC rule — but this research pass did not run a live marketplace check for these two specific REFRESH products.
Rather than assume eligibility by analogy to the surgery or to eye drops as a general category, we're stating that gap honestly. Check your own FSA/HSA administrator or a marketplace like FSAstore.com before assuming a specific product qualifies.
Recall check for these two specific picks
Neither REFRESH OPTIVE nor REFRESH PLUS (Allergan/AbbVie) appears in any of the 20 openFDA enforcement records returned for a live "artificial tears" search, 2026-07-30 — the recalled brands in that pull were EzriCare/Delsam Pharma (Global Pharma Healthcare), plus separate, unrelated CGMP-deviation recalls from Akorn and K.C. Pharmaceuticals. That's a real, on-topic check specific to these two products, not the broader out-of-scope disclosure some other categories on this site carry.
Related guides
LASIK recovery checklist
The full 3-item essentials list this pick comes from, plus the eye shield and sunglasses.
LASIK recovery, week by week
How the dry-eye window compares across FDA, Cleveland Clinic, and UVA Ophthalmology.
We may earn a commission if you buy through the links above, at no extra cost to you. It doesn't change which products we choose or how we describe them — see our methodology.
Sources
- FDA, "What Should I Expect During and After Surgery" (LASIK patient program) — source of the artificial-tears-need citation; fetched live 2026-07-30
- Cleveland Clinic, "LASIK Eye Surgery: What It Is, Procedure & Recovery" — dry eye named as "the most common issue" after LASIK
- FDA Drug Safety Communication, EzriCare Artificial Tears contamination warning — content current as of 08/25/2023; the Class I recall, CDC outbreak data, and root-cause citations above
- FDA openFDA drug/enforcement.json, live query 2026-07-30 — 20 records for "artificial tears," 174 for "eye drops" — source of the CVS/Kilitch and Alcon Systane recall records above; confirms neither REFRESH product is a recalled brand
- IRS Publication 502, "Eye Surgery" section — FSA/HSA basis for the surgery itself — see the honest per-item gap disclosed above
- IRS Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans — general OTC-eligibility rule referenced above
- Amazon product-page direct fetch (Chrome UA) — both picks verified live 2026-07-30 — title, price, brand, and cart/buy-now presence confirmed; Creators API catalog host DNS-failed this session, documented fallback in our methodology